Surveillance for dysplasia is necessary for patients with ulcerative colitis. PRO: Endoscopic surveillance minimizes the risk of cancer

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1631-1633

  Connell, William ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CAUSE OF DEATH; CHROMOSOME ANALYSIS; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DYSPLASIA; EARLY CANCER; ENDOSCOPY; FOLLOW UP; GASTROINTESTINAL BIOPSY; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MEDICAL SPECIALIST; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SAMPLING; SIGMOIDOSCOPY; ULCERATIVE COLITIS; AUSTRALIA; COLON TUMOR; FEMALE; HEALTH CARE QUALITY; MALE; MASS SCREENING; METHODOLOGY; MONITORING; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PRECANCER; PRIMARY PREVENTION; PROGRAM DEVELOPMENT;

AUSTRALIA; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; HUMANS; MALE; MASS SCREENING; MONITORING, PHYSIOLOGIC; PRECANCEROUS CONDITIONS; PREVALENCE; PRIMARY PREVENTION; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; RISK ASSESSMENT;

EID: 4544320873     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40829.x     Document Type: Review

References (21)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35.
2. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9.
3. Taylor BA, Pemberton JH, Carpenter HA, et al. Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950-6.
4. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
5. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60.
6. Lofberg R, Brostrom O, Karlen P, et al. Colonoscopic surveillance in long-standing total ulcerative colitis - A 15-year follow-up study. Gastroenterology 1990;99:1021-31.
7. Leidenius M, Kellokumpu I, Husa A, et al. Dysplasia and carcinoma in longstanding ulcerative colitis: An endoscopic and histological surveillance programme. Gut 1991;32:1521-5.
8. Lynch DA, Lobo AJ, Sobala GM, et al. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075-80.
9. Jonsson B, Ahsgren L, Andersson LO, et al. Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994;81:689-91.
10. Rozen P, Baratz M, Fefer F, et al. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995;108:1361-70.
11. Lindberg B, Persson B, Veress B, et al. Twenty years colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol 1996;31:1195-204.
12. Hata K, Watanabe T, Kazama S, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: Results of a 23-year surveillance programme in the Japanese population. Br J Cancer 2003;89:1232-6.
13. Rosenstock E, Farmer RG, Petras R, et al. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6.
14. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989;34:1536-41.
15. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
16. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
17. Provencale D, Kowdley KV, Arora S, et al. Prophylactic proctocolectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology 1995;109:1188-96.
18. Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut 2000;46:500-6.
19. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal mortality in ulcerative colitis? A population based case control study. Gut 1998;42:711-4.
20. Lim CH, Dixon MF, Vail A, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003;52:1127-32.
21. Ullman T, Croog V, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;125:1311-9.